0000874716-23-000113.txt : 20230831
0000874716-23-000113.hdr.sgml : 20230831
20230831171705
ACCESSION NUMBER: 0000874716-23-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230829
FILED AS OF DATE: 20230831
DATE AS OF CHANGE: 20230831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POLEWACZYK JAMES F
CENTRAL INDEX KEY: 0001389046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 231229477
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1693516123.xml
FORM 4
X0508
4
2023-08-29
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001389046
POLEWACZYK JAMES F
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
0
Common Stock
2023-08-29
4
M
0
2627
68.75
A
18664.9875
D
Common Stock
2023-08-29
4
M
0
706
141.60
A
19370.9875
D
Common Stock
2023-08-29
4
M
0
7151
141.60
A
26521.9875
D
Common Stock
2023-08-29
4
M
0
560
178.26
A
27081.9875
D
Common Stock
2023-08-29
4
M
0
5865
178.26
A
32946.9875
D
Common Stock
2023-08-29
4
S
0
500
508.9642
D
32446.9875
D
Common Stock
2023-08-29
4
S
0
2545
509.3207
D
29901.9875
D
Common Stock
2023-08-29
4
S
0
6186
510.3776
D
23715.9875
D
Common Stock
2023-08-29
4
S
0
3318
510.4664
D
20397.9875
D
Common Stock
2023-08-29
4
S
0
7473
511.0286
D
12924.9875
D
Common Stock
2023-08-29
4
S
0
2887
511.2237
D
10037.9875
D
Non-Qualified Stock Option (right-to-buy)
68.75
2023-08-29
4
M
0
2627
0
D
2026-02-13
Common Stock
2627
0
D
Incentive Stock Option (right-to-buy)
141.60
2023-08-29
4
M
0
706
0
D
2027-02-13
Common Stock
706
0
D
Non-Qualified Stock Option (right-to-buy)
141.60
2023-08-29
4
M
0
7151
0
D
2027-02-13
Common Stock
7151
0
D
Incentive Stock Option (right-to-buy)
178.26
2023-08-29
4
M
0
560
0
D
2028-02-13
Common Stock
560
0
D
Non-Qualified Stock Option (right-to-buy)
178.26
2023-08-29
4
M
0
5865
0
D
2028-02-13
Common Stock
5865
0
D
Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023.
Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
Grant of option to buy 7,151 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023.
Grant of option to buy 5,865 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
2023-08-31